Filip Janku, Chief Medical Officer: Monte Rosa Therapeutics GLUE Planned sale · Filed 06/23

Trade details

Type: Planned sale notice
Stock: Monte Rosa Therapeutics GLUE
Person: Filip JankuChief Medical Officer
Planned sale date: 26/06/23
Filed: 26/06/23

$221.1K to be sold

Monte Rosa Therapeutics trades, last 26 weeks

What else happened in Monte Rosa Therapeutics around then

Filed or reported within 30 days of the trade day · 05/24~07/23

Filip Janku's recent trades

Filip JankuChief Medical Officer
Planned sale10b5-1 planMonte Rosa Therapeutics
Planned sale10b5-1 plan
Monte Rosa Therapeutics
GLUE
$129.2K
5,407 sh
$129.2K
Filed 06/30
Traded 06/30
Filip JankuChief Medical Officer
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 plan
Monte Rosa Therapeutics
GLUE
$137.7K
6,000 sh
$137.7K
Filed 06/30
Traded 06/29
Filip JankuChief Medical Officer
Planned sale10b5-1 planMonte Rosa Therapeutics
Planned sale10b5-1 plan
Monte Rosa Therapeutics
GLUE
$133.7K
6,000 sh
$133.7K
Filed 06/29
Traded 06/29
Filip JankuChief Medical Officer
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 plan
Monte Rosa Therapeutics
GLUE
$642.6K
30,000 sh
$642.6K
Filed 06/25
Traded 06/24
Filip JankuChief Medical Officer
Sell10b5-1 planMonte Rosa Therapeutics
Sell10b5-1 plan
Monte Rosa Therapeutics
GLUE
$239.5K
11,845 sh
$239.5K
Filed 06/25
Traded 06/23

Filip Janku, Chief Officer — plans to sell 11,845 sh of Monte Rosa Therapeutics GLUE · $221.1K · around 06/23 · 10b5-1 plan | Whalegun